Workflow
Why Bluebird Bio Stock Flew Higher Than the Market Today
BLUEbluebird bio(BLUE) The Motley Fool·2024-03-18 22:05

Like many biotechs, Bluebird Bio's (BLUE 1.41%) stock has been volatile over its lifetime. The company, which specializes in gene-editing therapies, has struggled with high costs and limited patient populations for two of its three approved products, plus looming competition for the third. The company was thrown something of a financial lifeline on Monday, however. Cautiously optimistic investors pushed the stock's price up by 1.4% in reaction. That was good enough to beat the S&P 500 index's 0.6% bump high ...